预测早期出现的大型抑郁症的自杀企图:基于名录的方法
Nan Lyu1, Han Wang1, Juan Huang2
1Beijing Key Laboratory of Mental Disorders, National Clinical Research Center for Mental Disorders & National Center for Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, 100088, China; Laboratory for Clinical Medicine, Capital Medical University, Beijing, China.
Journal of psychiatric research
|October 27, 2025
概括
这项研究开发了一种模型,使用临床和生物数据估计早期出现主要抑郁症 (MDD) 患者的自杀企图风险. 该模型显示适度的预测能力,有助于早期干预这种严重的心理健康状况.
科学领域:
- 精神病学是一个精神病学.
- 临床心理学 临床心理学
- 生物医学数据科学 生物医学数据科学
背景情况:
- 早期出现的大型抑郁症 (MDD) 与严重疾病,慢性和自杀风险增加有关.
- 在这个人群中开发自杀企图 (SA) 的预测模型对于及时干预至关重要.
- 临床数据的回顾性分析旨在确定早期MDD中SA的风险因素.
研究的目的:
- 构建和验证早期出现严重抑郁症 (MDD) 患者自杀企图 (SA) 的初步预测模型.
- 确定与SA相关的关键的人口,临床和生化预测因素.
主要方法:
- 在2013-2023年间对早期发病的MDD患者 (发病年龄 ≤25岁) 的回顾性分析.
- 利用多变量后勤回归,十倍交叉验证,ROC曲线和DCA来构建和评估预测模型.
- 包括诸如人口统计学,临床病史,酒精/烟草使用和生物化学标记 (叶酸,ACTH,同氨酸) 等变量.
主要成果:
- 自杀未遂者 (MDD-S) 和未尝试者 (MDD-N) 在饮酒,吸烟,教育,叶酸水平和治疗方式方面发现了显著差异.
- 开发了一个包含性别,职业,教育,婚姻状况,烟草/酒精使用,ACTH和叶酸水平的诺莫图.
- 该模型显示了中等的分辨性性能 (C指数=0.734,AUC=0.734),通过DCA证实了良好的临床效用.
结论:
- 通过使用临床和生物数据,成功开发了早期MDD患者SA风险的预测模型.
- 该模型表现出适度的预测准确性和临床有用性.
- 建议在更大,多样化的群体中进行进一步验证,以提高可通用性.
相关概念视频
Dosage Regimen Designs: Nomograms and Tabulations
174
Nomograms and tabulations are vital tools used by clinicians to design accurate and individualized dosage regimens. These instruments provide a straightforward method for adjusting dosages based on individual patient characteristics, including age, weight, and physiological condition. The foundation of a drug's nomogram is population pharmacokinetic data collected and analyzed using specific models. This data simplifies complex equations, presenting them diagrammatically or tabularly for easy...
174
Depressive Disorders: Etiology
433
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
433
Depressive Disorders: MDD and Dysthymia
618
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
618
Antidepressant Drugs: MAOIs and Other Agents
797
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
797
Depression: Overview
768
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
768
Survival Tree
382
Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
Building a Survival Tree
Constructing a...
Building a Survival Tree
Constructing a...
382


